Bolder BioPath

About Us
Services
Publications
Request a Quote
Contact

Systemic Autoimmune Rheumatic Diseases (SARD)
Rheumatoid Arthritis (RA)
Osteoarthritis (OA)
Inflammatory Bowel Disease (IBD)
Central Nervous System (CNS)
Animal Models of Lupus
Animal Models of Anemia
Animal Models of Pain
General Inflammation
Cancer
Toxicology and Pharmacokinetic Studies
Ex Vivo Services
Pathology
Model Development

Systemic Autoimmune Rheumatic Diseases (SARD)
Rheumatoid Arthritis (RA)
Osteoarthritis (OA)
Inflammatory Bowel Disease (IBD)
Central Nervous System (CNS)
Animal Models of Lupus
Animal Models of Anemia
Animal Models of Pain
General Inflammation
Cancer
Toxicology and Pharmacokinetic Studies
Ex Vivo Services
Pathology
Model Development

Models We Conduct

Histotype

Lung
Colon
Breast
Prostate
Ovarian
Renal
CNS
Pancreatic
Leukemia
Other

Renal

Tumor Cell Lines (Click to Enlarge Image):

: rxf631

: sn12c

: sn12k1

Tell Us About Your Project! Get a Quote »

Contact Us

CAPTCHA
Comments
This field is for validation purposes and should be left unchanged.

Recent Posts

Please come join us at the Keystone Symposia on Tissue Immunity (Jan 26-29, 2020 in Boulder, CO)
12-02-19
Summary of meeting: How tissues integrate host-microbial signals and regulate immune responses has a critical impact on health and disease. However, our understanding of tissue immunity is limited because of difficulties in accessing the different organs and also due to the inherent complexity and individuality of the cellular circuits present in different tissues. This conference […]
Exciting Changes Coming in 2020!
10-08-19
BBP is expanding into an additional 16,000 sf, with updated wet labs and a second vivarium. New disease areas and models coming in 2020!
A Novel ROR-Gamma Inhibitor (VPR-254) Attenuates Key Parameters of Innate Immune Colitis in Mice
05-02-17
Come hear Leo Fitzpatrick discuss the paper, A Novel ROR-Gamma Inhibitor (VPR-254) Attenuates Key Parameters of Innate Immune Colitis in Mice, this Saturday May 6, from 10:30am-10:45am in Room S102d at McCormick Place, California NorthState University College of Pharmacy. Authors: Leo Fitzpatrick, Robert O’Connell, George Talbott, Phillip Bendele, Gordon Alton, Jim Zapf
AAALAC Accreditation
03-14-17
Bolder BioPATH now has FULL accreditation through AAALAC International, effective as of March 9, 2017.
OARSI 2017 World Congress on Osteoarthritis
01-24-17
Come meet Bolder BioPATH at the OARSI 2017 World Congress on Osteoarthritis in Las Vegas from April 27 to 30! We’ll be set up in booth #8.
Digestive Disease Week Conference, May 6-9
12-22-16
Come meet Bolder BioPATH at the DDW Conference in Chicago from May 6 to 9! We’ll be set up in booth #1712.
Important Things to Know About Intra-Articular Testing of Drugs in Animals – ACT’s 37th Annual Meeting
08-25-16
Important Things to Know About Intra-Articular Testing of Drugs in Animals Alison M. Bendele DVM, PhD, DACVP Bolder BioPATH, Inc, Boulder, CO Monday Nov. 7th – Symposium 7 , 3:50 PM–4.20 PM Intra-articular (IA) administration of drugs offers an opportunity to directly target joints (primarily osteoarthritic) for anabolic, antidegenerative, analgesic, lubricant, anti-inflammatory and other potential […]
Now offering FACS analysis through Clinimmune Labs.
08-23-16
Bolder BioPATH has started offering FACS analysis on some of our models with help from the folks at Clinimmune Labs in Denver.

Website designed by Studio98

In Vivo efficacy models
Ex Vivo Services
Pathology
Terms of Service
Privacy Policy

©2020 Bolder BioPATH, INC. All rights reserved.Privacy Policy